Etiologic Diagnosis of Infective Endocarditis by Broad-Range Polymerase Chain Reaction: A 3-Year Experience by Bosshard, Philipp Peter et al.
Broad-Range PCR in Infective Endocarditis • CID 2003:37 (15 July) • 167
M A J O R A R T I C L E
Etiologic Diagnosis of Infective Endocarditis
by Broad-Range Polymerase Chain Reaction:
A 3-Year Experience
Philipp Peter Bosshard,1,a Andreas Kronenberg,2,a Reinhard Zbinden,1 Christian Ruef,2 Erik Christian Bo¨ttger,1
and Martin Altwegg1
1Institute of Medical Microbiology, University of Zurich, and 2Division of Infectious Diseases and Hospital Epidemiology, University Hospital
of Zurich, Zurich, Switzerland
We analyzed surgically resected endocardial specimens from 49 patients by broad-range PCR. PCR results
were compared with (1) results of previous blood cultures, (2) results of culture and Gram staining of resected
specimens, and (3) clinical data (Duke criteria). Molecular analyses of resected specimens and previous blood
cultures showed good overall agreement. However, in 18% of patients with sterile blood cultures, bacterial
DNA was found in the resected materials. When data from patients with definite or rejected cases of infective
endocarditis (IE) were included, the sensitivity, specificity, and positive and negative predictive values of broad-
range PCR were 82.6%, 100%, 100%, and 76.5%, respectively, overall, and 94.1%, 100%, 100%, and 90%, for
cases of native valve endocarditis. The sensitivity, specificity, and positive and negative predictive values of
culture of resected specimens from patients with native valve endocarditis were 17.6%, 88.9%, 75%, and 36.4%.
We recommend broad-range PCR of surgically resected endocardial material in cases of possible IE, in cases
of suspected IE in which blood cultures are sterile, and in cases in which organisms grow in blood cultures
but only Duke minor criteria are met. We propose to add molecular techniques to the pathologic criteria of
the Duke classification scheme.
Infective endocarditis (IE), infection of the endocar-
dial surface, is a rare but severe disease. In Europe,
the incidence is ∼6–7 cases/100,000 person-years [1,
2], and the overall mortality rate is 20%–25%, de-
pending on the causative microorganism and the pres-
ence of complications and comorbidities [3]. IE is
usually diagnosed according to the Duke scheme, by
clinical or pathologic criteria (i.e., histologically con-
firmed pathologic lesions or demonstration of a caus-
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ative microorganism by culture or histologic exami-
nation in a sample from a vegetation, an embolism,
or an intracardiac abscess) [4, 5]. The Duke clinical
criteria include major criteria (i.e., blood culture pos-
itive for IE, echocardiographic findings consistent
with IE, and valvular regurgitation) and minor criteria
(i.e., predisposition, fever, vascular and immunologic
phenomena, and growth of organism in blood cultures
but failure to meet a major criterion). In large series,
blood cultures were sterile in 2.5%–31% of cases of
IE [6]. Blood cultures often are sterile as a result of
previous antibiotic therapy [1] or because of fastidious
and difficult-to-cultivate microorganisms such as HA-
CEK group bacteria, Bartonella species, Coxiella bur-
netii, Legionella species, Mycoplasma species, and Tro-
pheryma whipplei [7, 8]. In such cases, the etiologic
agent may be identified by serologic and/or immuno-
histologic techniques [9]. Recent case reports have
shown the usefulness of broad-range amplification of
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16S rDNA (referred to as “broad-range PCR”) for identifi-
cation of the causative agent of IE [10–14]. However, only a
few studies so far have addressed the utility of nucleic acid
amplification techniques for diagnosis of IE in a systematic
fashion [15, 16].
For 14 years, we have used broad-range PCR as part of our
microbiological workup procedure for endocardial specimens
[15]. We here report a retrospective study that included 49
patients who were referred for endocardial surgery during Jan-
uary 1998 through March 2001. Our main focus was to com-
pare the results of broad-range PCR with those of standard
microbiological procedures, to evaluate the clinical utility of
broad-range PCR for the diagnosis of IE, and thus to suggest
possible guidelines for the use of broad-range PCR in clinical
practice.
PATIENTS AND METHODS
Patients. From January 1998 through March 2001, all pa-
tients ( ) from a tertiary health care center in Zurichnp 49
(University Hospital of Zurich) who had been referred for en-
docardial surgery and from whom specimens had been sub-
mitted to the Institute of Medical Microbiology (University of
Zurich) were included in this study. Clinical and pathologic
data, including blood culture results for up to 6 months before
surgery, were collected from the medical records, and cases were
classified according to the modified Duke criteria [5]. Forty-
two patients (86%) were male, and 7 (14%) were female; the
mean age (SD) was 55 years (17 years; range, 10–83 years).
Twenty-two patients had definite IE and 13 patients had pos-
sible IE according to the modified Duke criteria [5]; in 14
patients, surgery was performed because of valvular dysfunction
(IE was excluded on the basis of the Duke criteria). Eighteen
patients (37%) had prosthetic valves before surgery. A total of
63 specimens were obtained and analyzed, 52 of which were
valves (38 aortic valves and 14 mitral valves) and 11 of which
were of other materials, such as aortic vessels ( ), swabsnp 7
from the aortic valve ( ), and a vegetation on a pacemakernp 3
( ). In 39 patients, blood samples were obtained for culturenp 1
before surgery. For these patients, on average 6.9 blood cultures
(range, 1–25 cultures; each blood culture consisted of 1 aerobic
and 1 anaerobic bottle) were done. Eleven additional patients
previously had had IE and underwent surgery because of val-
vular dysfunction (anti-infective therapy had been completed
between 8 days and 8.5 years before surgery).
Cultures. Cultures were performed as described elsewhere
[15]. Briefly, aerobic and anaerobic blood cultures (BacT/Alert)
were incubated at 37C for at least 6 days. If growth was found
in blood cultures, aliquots were subcultured on Columbia sheep
blood agar (Difco) and on brucella sheep blood agar (Becton
Dickinson BBL). Single blood cultures positive for Propioni-
bacterium acnes or coagulase-negative staphylococci were rated
as contaminated. Parts of endocardial specimens were ground,
prepared for Gram staining, and cultured aerobically and an-
aerobically on Columbia sheep blood agar, chocolate agar (GC
II Agar base with 1% hemoglobin and 1% IsoVitaleX; BBL),
and Brucella sheep blood agar (BBL) for 2–3 days at 37C. In
addition, pieces of valve tissue were inoculated into thiogly-
colate medium (BBL) and incubated for 10 days.
DNA extraction and broad-range PCR. DNA extraction
and broad-range PCR were performed essentially as described
elsewhere [15]. In brief, small pieces of tissue were digested
with proteinase K in the presence of 0.5% SDS. DNA was
purified with the QIAamp Blood Kit (Qiagen), resulting in a
sample volume of 100 mL. One and 5 mL of the DNA extract
were used for amplification in a total volume of 50 mL con-
taining 1.25 U of AmpliTaq DNA polymerase, LD (Applied
Biosystems). Part of the 16S rDNA (positions 10–806, accord-
ing to Escherichia coli numbering [17]) was amplified with
primers BAK11w (5′-AGTTTGATC[A/C]TGGCTCAG) and
BAK2 (5′-GGACTAC[A/C/T]AGGGTATCTAAT) for 40 cycles.
Insulin-like growth factor II amplification with primers IGF-
P2 (5′-CTTGGACTTTGAGTCA) and IGF-P3 (5′-GGTCGTG-
CCAATTACA) was used as inhibition control.
The amplicons were examined by high-resolution polyacryl-
amide gel electrophoresis (CleanGel; Pharmacia) in which silver
staining was used. Positive samples were recognized by a single
prominent band of appropriate size; negative samples were
those that generated a characteristic banding pattern with sev-
eral bands of smaller size (i.e., 100–200 bp instead of 800 bp)
and low intensity. Bands of proper size were excised and ream-
plified (positions 10–533, according to E. coli numbering) with
primers BAK11w and BAK533r (5′-TTACCGCGGCTGCTGG-
CAC) for 40 cycles using 1.25 U of Taq DNA polymerase (Amer-
sham Biosciences) [15]. For reamplification, a piece of the excised
band was added directly to the reamplification mix without prior
purification of the DNA. To prevent carry-over contamination,
we used physically separate rooms for sample preparation, setup
of PCR mixes, nucleic acid amplification, and analysis of PCR
products. In addition, several negative and positive controls for
DNA extraction and amplification were used.
Occasionally, contaminating DNA was observed both in neg-
ative controls and in patient samples. Although the contami-
nating DNA produced a band that was similar in size to that
seen in positive samples when high-resolution polyacrylamide
gel electrophoresis was done, this was always less prominent
than in the case of true-positive samples. Sequence analyses
demonstrated that this reagent contamination derived from
waterborne Pseudomonas species.
Sequence analysis. The nucleic acid sequence of PCR-
amplified gene fragments was determined using automatic
DNA sequencing (ABI Prism 310 Genetic Analyzer [Applied
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Table 1. Results of broad-range PCR compared with results of
culture and microscopic examination of endocardial specimens.
Specimen status
Results of
broad-range PCR,
no. of specimens
Positive
(n p 25)
Negative
(n p 38)
Culture-positive,
microscopy-negative 3a 3b
Culture-negative,
microscopy-positive 7c 1d
Culture-positive,
microscopy-positive 0 0
Culture-negative,
microscopy-negative 15 34
a In 1 case, results were contradictory; viridans streptococci were recovered
on culture, but broad-range PCR yielded a sequence with 100% identity with
3 different Staphylococcus species (S. arlettae, S. capitis, and S. capprae).
b Two samples showed growth of Propionibacterium acnes (samples were
from 2 swabs of the aortic valve from the same patient). Coagulase-negative
staphylococci grew on culture of a sample from another patient after enrich-
ment in liquid medium. These 2 patients did not have any other clinical or
pathologic evidence of infective endocarditis, and therefore the PCR results
were considered to be true negative.
c In all 7 microscopy-positive samples, PCR results were congruent (i.e.,
both diagnostic procedures revealed gram-positive cocci).
d The results of both PCR and microscopic examination of a second sample
from the same patient were positive.
Table 2. Results of broad-range PCR in endocardial specimens
compared with cultures of previously drawn blood samples.
Blood culture results
No. of
patients
(n p 49)
Results of
broad-range PCR,
no. of patients
Positive
(n p 23)
Negative
(n p 26)
Positive for any organism 22 19 3
Fulfilled Duke major criteriaa 18 17 1b
Did not fulfill Duke major cri-
teria for IE but did fulfill
Duke minor criteria 4 2 2c
No organisms grown on culture 17 3d 14
Not done 10 1 9
NOTE. IE, infective endocarditis.
a Microorganism typical of IE found in at least 2 separate blood cultures or
microorganism consistent with IE found persistently in blood cultures
b Patient had definite IE, according to Duke criteria (Staphylococcus aureus
was found in 7 of 7 blood cultures). Results of PCR were negative, although
antibiotic therapy was started only 4 days before surgery (false-negative PCR).
c Includes 1 patient with coagulase-negative staphylococci in 3 of 10 blood
cultures and 1 patient with Propionibacterium acnes in 7 of 21 blood cultures.
PCR results were considered to be false negative in both cases.
d PCR results were considered to be true positive; for more details, see
Results.
Biosystems] and ALF automatic DNA sequencer [Pharmacia]).
Database analysis was done in a 2-step procedure. A first search
was performed with the FASTA algorithm of the GCG Wis-
consin software package (Accelrys). All positions showing dif-
ferences from the best scoring reference sequence were visually
inspected in the electropherogram, and the sequence was cor-
rected if necessary. Then a second search was done using BLAST
(http://www.ncbi.nlm.nih.gov/blast). Undetermined nucleo-
tides in the determined sequence or the reference sequence were
counted as matches. For identification to the genus or species
level, the following criteria were used: 0–2 mismatches with the
sequence entry of an established species was interpreted as spe-
cies identification, and 0–2 mismatches with the sequence entry
of an unclassified species or 12 mismatches with the highest-
score entry was interpreted as genus identification.
RESULTS
Broad-range PCR versus culture and microscopic examination
of resected specimens. In 2 of the 63 specimens we investigated,
PCR was inhibited (in these patients, cultures of previously ob-
tained blood samples were sterile). The results of broad-range
PCR were positive in 25 specimens from 23 patients, and 15 of
these specimens were culture and microscopy negative (table 1).
Five sequences were identified at the genus level, and 20 se-
quences could be assigned to a species. Three samples were cul-
ture positive and PCR negative; in these cases, the culture results
were considered to be false positive (table 1).
Broad-range PCR versus blood culture. Of the 39 patients
from whom blood samples were obtained for culture before
surgery (mean number of blood cultures, 6.9; range, 1–25 cul-
tures), 22 had at least 1 positive blood culture (mean number
of positive blood cultures, 5.8; range, 1–19 cultures) (table 2).
The results of PCR in samples from 19 of these 22 patients
were positive (table 3). For 13 patients (68%), both procedures
resulted in identification of the same species; for 6 (32%) of
the 19 patients, PCR yielded a more precise result (e.g., Strep-
tococcus salivarius instead of viridans streptococcus, or an un-
classified oral Streptococcus species instead of Streptococcus oralis
or Streptococcus sanguis). In the latter case, the obtained se-
quence exactly matched that of an unclassified oral Streptococcus
species sequence but exhibited !98% homology to the most
closely related established species, S. sanguis. The 3 patients for
whom blood culture results were positive but PCR results were
negative had definite IE, according to the Duke criteria; the
PCR results were considered to be false negative (table 2).
For 3 patients, the results of PCR were positive, even though
the results of blood cultures (at least 2 pairs), microscopic
examination, and culture of endocardial specimens were neg-
ative (table 2). In all 3 cases, the results of PCR were considered
to be true positive. For 2 of these patients, IE was diagnosed
as “possible,” according to the Duke criteria; PCR found Hae-
mophilus aphrophilus in one case and Streptococcus bovis in the
other. Both patients were receiving antibiotics at the time that
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Table 3. Organisms identified by blood culture and broad-range PCR in samples from 19 patients
with infective endocarditis for whom both methods had positive results.
Bacterial group, patient Identification by broad-range PCR Identification by blood culture
Viridans streptococci
1 Streptococcus australis Streptococcus mitis
2 Streptococcus bovis S. bovis
3 S. bovis/gallolyticus S. bovis
4 Streptococcus gordonii S. gordonii
5 S. mitis S. mitis
6 and 7 Streptococcus mutans S. mutans
8 Streptococcus salivarius Viridans streptococcus
9 and 10 Unclassified oral streptococcus S. mitis
11 and 12 Unclassified oral streptococcus Streptococcus oralis/sanguis
Enterococci
13 and 14 Enterococcus faecalis E. faecalis
Staphylococci, 15–18 Staphylococcus aureus S. aureus
Haemophilus species, 19 Haemophilus parainfluenzae/paraphrophilus H. parainfluenzae
blood samples (10 and 3 pairs) were obtained for culture. In
the third patient, T. whipplei was identified by PCR. This patient
underwent surgery for aortic insufficiency. The valvular path-
ology, described as “lymphoplasmacellular inflammation with
formation of granulomas and fibrosis,” was interpreted as sterile
endocarditis in a patient with seronegative spondylarthritis.
However, 2 different PCRs specific for T. whipplei (targeting a
different part of the 16S rDNA and the ribosomal intergenic
spacer region [18, 19]) were performed on aortic material,
confirming the results of broad-range PCR. These findings
make it unlikely that laboratory contamination occurred, be-
cause for each PCR, a specific positive control is used that only
includes the region of interest. From these data, we concluded
that T. whipplei most probably was the true cause of IE in this
case (true-positive PCR result). The patient has not yet shown
other manifestations of Whipple disease. Cases of Whipple en-
docarditis in the absence of overt gastrointestinal disease [11]
or without other signs of Whipple disease have been reported
elsewhere [10, 20].
Sensitivity, specificity, and positive and negative predictive
values of assays. According to the Duke criteria, which in-
clude clinical and pathologic features, 22 patients were consid-
ered to have definite IE; 13 patients, possible IE; and 14 patients,
no (“rejected”) IE. The patient with Whipple endocarditis was
considered to have definite IE, resulting in the inclusion of 23
patients with definite IE and 13 patients with rejected IE in
our study. Broad-range PCR results were positive for 19 of 23
patients with definite IE, 4 of 13 patients with possible IE, and
0 of 13 patients with rejected IE (table 4).
Definite and rejected cases of IE were used as the reference
standard for calculating the sensitivity and specificity of broad-
range PCR. Overall, sensitivity was 82.6%, specificity was 100%,
positive predictive value was 100%, and negative predictive
value was 76.5%. Six patients with definite IE, 8 patients with
possible IE, and 4 patients with rejected IE had prosthetic valves.
Broad-range PCR was positive in samples from 16 of 17 of the
patients with definite native valve endocarditis (NVE) but only
in 3 of 6 of the patients with definite prosthetic valve endo-
carditis (PVE). The sensitivity, specificity, and positive and neg-
ative predictive values of broad-range PCR were 94.1%, 100%,
100%, and 90%, respectively, when the analysis was limited to
cases of NVE and 50%, 100%, 100%, and 42.9% when the
analysis was limited to cases of PVE.
Organisms grew on culture of resected specimens from 3 of
23 patients with definite IE (3 of 17 patients with NVE), 0 of
13 patients with possible IE, and 2 of 13 patients with rejected
IE (1 of 9 cases with NVE and 1 of 4 cases with PVE). The
sensitivity, specificity, and positive and negative predictive val-
ues for culture of resected specimens were 13%, 84.6%, 60%,
and 35.5%, respectively, overall, and 17.6%, 88.9%, 75%, and
36.4% when the analysis was limited to cases of NVE. The
failure to obtain a positive result for specimens from any of
the patients with PVE makes statistical analysis irrelevant but
indicates the limited use of culture techniques in this context.
Patients with previous IE. Eleven additional patients pre-
viously had had IE. Adequate anti-infective therapy had been
completed between 8 days and 8.5 years before surgery. The
patients underwent surgery because of valvular dysfunction in
the absence of acute signs of endocarditis. In 6 patients, the
results of PCR were positive. In these cases, diagnosis was made
1, 2, 4, 7, and 23 months before surgery. Two of these patients
were intravenous drug users who had multiple episodes of IE
16 months before surgery. The cultures of blood samples from
both patients were positive for Staphylococcus aureus and Strep-
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Table 4. Comparison of culture and broad-range PCR in patients
with infective endocarditis (IE) according to the Duke classifi-
cation scheme.
Duke category
Total no.
of patients
(n p 60)
No. of patients
with positive results
of culture
No. of
patients with
positive results
of PCR
(n p 60)
Blood
sample
(n p 49)
Resected
specimen
(n p 60)
Definite IE 23 20a 1 19
Possible IE 13 2 0 4
Rejected IE 13 0a 3b 0
Previous IEc 11 5a 0 6
a Blood cultures were done for only 22 patients with definite IE, 4 with
rejected IE, and 10 with previous IE.
b These 3 patients did not have any other clinical or pathologic evidence of
IE; culture results were considered to be false positive. Cultures were done
for only 13 patients.
c Anti-infective therapy was suspended for a period ranging from 8 days to
8.5 years before surgery.
tococcus dysgalactiae (in 1 patient, Streptococcus pyogenes was
also found). In both cases, histologic examination revealed
chronic inflammation; PCR in resected specimens identified S.
dysgalactiae (isolated in blood cultures from these 2 patients 7
and 23 months before valve replacement).
DISCUSSION
In this study, we used a combination of broad-range PCR of
16S rDNA and nucleic acid sequencing to identify the causative
agent of IE. We analyzed all patients of a tertiary care hospital
who were referred for endocardial surgery during a 3-year pe-
riod and from whom specimens were submitted to our labo-
ratory. In addition to patients with definite or possible IE,
patients with no suspicion for IE and patients with a previous
episode of IE were included in this study.
Our study demonstrates that broad-range PCR is a useful
tool for the analysis of resected heart valves. For the majority
of PCR-positive specimens, no organisms were found by culture
on standard media or by microscopic examination. This is
probably because 90% of the patients had received antibiotics
before surgery. PCR results were in strong agreement with the
results of culture of previously obtained blood samples, and
sequencing provided more-accurate results in 33% of cases
(tables 2 and 3). However, imprecise identification by tradi-
tional techniques did not affect management of patients. None-
theless, for epidemiological reasons, a precise identification of
the causative agent is important.
IE usually is diagnosed by the Duke criteria, which have been
accepted by most clinicians [4]. The Duke criteria build on the
earlier published Beth Israel criteria [21] by including echo-
cardiographic findings and the isolation of typical IE pathogens
from blood cultures as major criteria for a clinically definite
categorization of IE. Further modification was proposed by Li
et al. [5] and Fournier et al. [22]. On the basis of our experience,
we propose that nucleic acid amplification–based detection and
identification of IE pathogens from endocardial specimens
should be included in the Duke criteria (i.e., a microorganism
can be demonstrated by culture, histologic examination, or
molecular-based techniques to fulfill a pathologic criterion and
thus to contribute to the definite diagnosis of IE). This proposal
is supported by the fact that PCR is far more sensitive and
specific than culture of resected specimens, a procedure which
is accepted as a pathologic criterion. More recently, Millar et
al. [16] suggested that molecular-based diagnosis of IE using
blood cultures be included as an additional major criterion
within the Duke clinical criteria. In this study, the authors used
PCR to identify DNA extracted from blood cultures and showed
the feasibility of identifying the causative agent in cases of
blood culture–negative IE [16].
The present study indicates that, if broad-range PCR of re-
sected specimens is included among the pathologic Duke cri-
teria, cases that otherwise were classified as possible IE may be
classified as definite IE, regardless of the result of culture of
previously obtained blood samples. Four of 13 patients with
possible IE in this study would have been classified as having
definite IE on the basis of a positive PCR result. For the other
9 patients in this group, the negative PCR result did not exclude
IE. The clinical and pathologic investigations performed in this
study did not allow strict definition of whether these patients
had or did not have IE, and therefore those cases were classified
as “possible IE.” Blood culture results that fit the Duke minor
criteria often are associated with some uncertainty; PCR results
from endocardial specimens may verify the causative agent and
aid the clinician in interpretation of culture findings. Broad-
range PCR may be helpful for cases of so-called blood culture–
negative IE [11, 23, 24]. In the present study, PCR made it
possible to diagnose and identify the cause of IE for 23% of
the patients with definite or possible blood culture–negative IE.
The sensitivity, specificity, and positive and negative predic-
tive values of broad-range PCR were calculated to be 82.6%,
100%, 100%, and 76.5%, respectively. When only cases of NVE
were included in the analysis, the sensitivity and negative pre-
dictive value increased to 94.1% and 90%, respectively. In spite
of the excellent specificity, a positive PCR result always has to
be interpreted within the clinical context; even several months
after therapy for IE has been completed, PCR results may still
be positive. The low sensitivity of 50% found when only cases
of PVE are included in the analysis highlights the difficulty of
obtaining the correct piece of specimen—if mechanical pros-
thetic devices were collected, pieces of adjacent tissue had to
be used for digestion and DNA extraction, and this tissue is
not necessarily involved in infection [25].
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On the basis of the findings of the present study, we propose
to perform broad-range PCR in resected endocardial specimens
(1) in cases of possible IE, (2) in cases of blood culture–negative
suspected IE, and (3) in cases of growth in blood cultures that
fulfills the Duke minor criteria to verify the causative agent of
IE. Because of the limited availability of these highly specialized
molecular investigations, specimens should be sent to a labo-
ratory with experience in these techniques. The present data
also indicate that nucleic acid amplification techniques do not
yield additional information in cases of definite IE that fulfill
a Duke major criterion and in which microorganisms grow on
blood cultures or in cases with no evidence of IE. A limitation
of broad-range PCR is that it does not provide information
about antimicrobial susceptibility. Thus, routine culture and
susceptibility testing remain important cornerstones of the mi-
crobiological diagnosis of IE.
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